29 completed. 29 Phase 2, 4 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 29 | Completed 29 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 3 |
Follow Personal Satisfaction: new trials by email Literature Review of Personal Satisfaction trials Research Report on Personal Satisfaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabinoids as a Treatment for Insomnia in Major Depression 25:1 CBD/THC, 5:1 CBD/THC, Placebo - Insomnia, Depressive Disorder, Major | Phase 2 | Completed | St. Joseph's Healthcare Hamilton | 14 | 2023-08-28 | 2026-01-22 |
| Satisfaction With FreeStyle Libre 2 Monitoring Versus Capillary Blood Glucose Monitoring in People With DM2 FreeStyle Libre 2, flash glucose monitoring - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 50 | 2022-11-28 | 2024-10-03 |
| The CANabidiol Use for RElief of Short Term Insomnia 50 mg Cannabidiol (CBD), Placebo, 100 mg Cannabidiol (CBD) - Sleep Disturbance, Insomnia | Phase 2 | Completed | Bod Australia | 208 | 2022-05-01 | 2023-08-16 |
| Oxytocin to Treat PTSD Oxytocin, Placebo - PTSD | Phase 2 | Completed | VA Office of Research and Development | 180 | 2021-01-01 | 2026-03-11 |
| Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe Young Women of Today - Mental Health Disorder, Social Isolation | Phase 2 | Completed | West Chester University of Pennsylvania | 183 | 2018-10-01 | 2022-02-15 |
| Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload Deferasirox granule formulation, Deferasirox DT formulation - Transfusion-dependent Anemia | Phase 2 | Completed | Novartis Pharmaceuticals | 224 | 2015-10-21 | 2024-09-19 |
| Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology Problem Solving Therapy plus Moving Forward, Problem Solving Therapy - Depression, Anxiety | Phase 1 / Phase 2 | Completed | VA Office of Research and Development | 33 | 2014-04-01 | 2016-11-28 |
| Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders Activity Intervention, Healthy Diet Intervention - Mental Disorders | Phase 2 | Completed | Charite University, Berlin, Germany | 86 | 2014-04-01 | 2016-03-10 |
| Testing a Promising Treatment for Youth Substance Abuse in a Community Setting Contingency Management-Family Engagement, Treatment as Usual - Substance Abuse, Delinquency | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 101 | 2014-04-01 | 2018-07-06 |
| Mobile-Web Emotion Self-management Tool Jauntly, Online stress management information - Stress, Depression | Phase 2 | Completed | Oregon Center for Applied Science, Inc. | 298 | 2013-02-01 | 2015-01-27 |
| IOK Treatment Study IOK Killing Treatment, Wait list control group - Posttraumatic Stress Disorder | Phase 2 | Completed | VA Office of Research and Development | 33 | 2012-10-01 | 2016-02-23 |
| Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families Mission Reconnect, PREP - Stress, Depression | Phase 2 | Completed | Collinge and Associates, Inc. | 320 | 2012-09-01 | 2015-08-04 |
| Comparing Interventions To Improve The Well-Being Of Custodial Grandfamilies Behavioral Parent Training, Cognitive Behavioral Therapy, Psychosocial-Informational support - Custodial Grandparents | Phase 1 / Phase 2 | Completed | Kent State University | 343 | 2012-01-01 | 2020-10-19 |
| Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy Oral alprazolam, Sublingual alprazolam, Oral placebo - Diagnostic Esophagogastroduodenoscopy | Phase 2 / Phase 3 | Completed | Isfahan University of Medical Sciences | 220 | 2011-09-01 | 2013-10-18 |
| Efficacy of System Constellations in a General Population system constellations seminar - Psychological Well-being | Phase 2 / Phase 3 | Completed | Heidelberg University | 216 | 2011-02-01 | 2012-02-09 |
| Violence and Stress Assessment (ViStA) Project to Improve Post Traumatic Stress Disorder Management in Primary Care PCM, MEU - Stress Disorders, Post-Traumatic | Phase 2 | Completed | RAND | 404 | 2010-06-01 | 2016-09-02 |
| Eliciting Affect in Teens in a Virtual World (Project AVATAR) Virtual Reality, Health Promotion - HIV Infections | Phase 1 / Phase 2 | Completed | Rhode Island Hospital | 196 | 2010-05-01 | 2016-04-06 |
| Hormonal Factors in the Treatment of Anorexia Nervosa Testosterone, Placebo - Anorexia Nervosa, Eating Disorder | Phase 2 | Completed | Massachusetts General Hospital | 90 | 2010-04-01 | 2020-09-02 |
| Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding Tactile electrosurgical ablation probe, Hysteroscopic endometrial ablation - Dysfunction Uterine Bleeding | Phase 2 | Completed | Mostafa Hussein | 108 | 2010-04-01 | 2016-01-01 |
| Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors Motivational Interviewing, Healthy Lifestyles Education - Living Donation | Phase 2 | Completed | University of Pittsburgh | 113 | 2010-03-01 | 2022-03-02 |
Showing 20 of 29. Sign in to see all of them.
Psychological Well-Being (25) · Anxiety Disorders (7) · Depression (6) · Stress Disorders, Post-Traumatic (5) · Mental Disorders (3) · Sleep Initiation and Maintenance Disorders (3) · Depressive Disorder, Major (2) · Motor Activity (2) · Patient Compliance (2) · Phobia, Social (2) · Sleep Wake Disorders (2) · Altruism (1) · Anorexia Nervosa (1) · Coitus (1)
Behavior (29) · Mental Disorders (16) · Behavioral Symptoms (7) · Stress Disorders, Traumatic (5) · Trauma and Stressor Related Disorders (5) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Social Behavior (4) · Dyssomnias (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Sleep Disorders, Intrinsic (3) · Chemically-Induced Disorders (2) · Depressive Disorder (2)
Cognitive Behavioral Therapy (3) · Hypericum extract LI 160 (3) · (tris(diphenylphosphinomethyl)phenylborate)(p-tolylnitrido)iron(I) (1) · Alprazolam (1) · Cannabidiol (1) · Capsules (1) · Deferasirox (1) · Employment, Supported (1) · Escitalopram (1) · Health Promotion (1) · Motivational Interviewing (1) · Oxytocin (1) · Palliative Care (1) · Self-Help Groups (1) · Sodium Chloride (1)
National Center for Complementary and Integrative Health (NCCIH) (4) · VA Office of Research and Development (3) · Arizona State University (1) · Bod Australia (1) · Charite University, Berlin, Germany (1) · Collinge and Associates, Inc. (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Heidelberg University (1) · Isfahan University of Medical Sciences (1) · Kent State University (1) · Massachusetts General Hospital (1) · Medical University of South Carolina (1) · Mostafa Hussein (1) · Novartis Pharmaceuticals (1) · Oregon Center for Applied Science, Inc. (1)
United States (19) · Egypt (2) · Germany (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · France (1) · Hungary (1) · India (1) · Iran (1) · Italy (1) · Lebanon (1) · Malaysia (1) · Oman (1)
Kenneth Kobak, PhD (2) · Ahmad Shavakhi, M.D. (1) · Amy Birney, MPH, MCHES (1) · Anne Klibanski, MD (1) · Benicio N Frey, MD, MSc, PhD (1) · Bert Hayslip, Ph.D. (1) · Chiwoneso Tinago, PhD (1) · Cynthia Price, PhD (1) · Elizabeth B Khalil, BSc MSc PhD (Cant.) (1) · Erinne Meenaghan, NP (1) · Gregory Smith, Ed.D. (1) · Janet R Kahn, PhD, LMT (1) · Jochen Schweitzer-Rothers, Professor (1) · Julianne Christina Flanagan, PhD (1)
PMID 18457236, PMID 21663696, PMID 23924065, PMID 24251855, PMID 24977401, PMID 27678169, PMID 30188171, PMID 31219558, PMID 32561468, PMID 33393377, PMID 36798485, PMID 37957412
K08MH001662 (1), R01MH077596 (1), R01MH083657 (1), R01NR012256 (1), R21MH066131 (1), R21NR011149 (1), R42MH087322 (1)